drugset / Trial / NCT00546039
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to evaluate safety and mechanisms of possible chemopreventive effects of synthetic genistein (BONISTEIN™) in patients with localized prostate cancer undergoing laparoscopic radical prostatectomy.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-08
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Genistein | Other / unclassified | 30 mg | Oral |